Entrada Therapeutics Inc (TRDA)
EBITDA Growth
0.01%
Quarterly · Period ending:
TRDA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported0.01%period ending
Latest reported0.01%period ending
TRDA Quarterly EBITDA YoY % (-50.31% → 0.01%)
Year-over-year change
High-resolution chart · PNG
TRDA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 0.0095% | |
| -136.9932% | |
| -16,644.2688% | |
| -182.5142% | |
| -171.3658% | |
| -162.4614% | |
| -97.4529% | |
| -127.8528% | |
| 617.1262% | |
| 1,117.0798% | |
| 141.2089% | |
| 318.0781% | |
| 50.0308% | |
| 87.8671% | |
| -33.2965% | |
| -75.0889% | |
| -135.4234% | |
| -159.7144% | |
| -111.3735% | |
| -104.3005% | |
| -76.9972% | |
| -50.3073% |